We Are The Wound Company
By Nima Ahmadi, Co-founder and CEO
My earliest childhood memory is of one of my uncles, who suffered multiple amputations as a result of lower leg wounds. Having to witness first-hand the challenges that arose from these complications inspired my work in Guatemala in 2010, where for many months I built prosthetics for diabetic patients with foot wounds and amputations because I didn’t want people in less privileged countries suffering a fate like my uncle’s. When I returned to the United States, I had a clearer vision of how I would dedicate my life’s work. I decided to study Biomedical Computation and Bioengineering at Stanford with the hopes of getting the background needed to make a permanent change in the wound care industry.
After graduating from Stanford University, I went on to scale NovuHealth (now Icario) from 0 to 15 million Medicare Advantage and Medicaid patients. But I wanted to get back to my calling in wound care so I joined Cardiovascular Systems (now Abbott), the world's leading amputation prevention medical device company. Being at Cardiovascular Systems, I realized the healthcare system needed an entirely new model of end-to-end care for patients—one that aligned incentives between patients, providers, and health plans, and leveraged cutting-edge technology to scale access to wound care expertise. And that’s exactly what we set out to create with The Wound Company.
With 154,000 amputations occurring in 2022 alone, along with a 75% increase in diabetes-related amputations over the past decade, healthcare—particularly wound care—is in dire need of a solution. And The Wound Company is already driving stronger outcomes for real patients by healing wounds, decreasing hospital admissions, and reducing costs for patients and providers. We’re connecting patients and providers to the wound care expertise they need to heal every day and in doing so actively solving one of the biggest healthcare challenges of the decade.
The bleak reality of outcomes for people suffering from wounds means that many of us, particularly those belonging to marginalized communities, are forced to settle with care that underdelivers almost by design as a result of long-standing disparities in the healthcare system. From biases that translate to adverse medical decisions among racial minorities to Black diabetic patients losing limbs 3x more frequently, the most innovative healthcare solutions are often reserved for the most privileged (i.e., those who already have unhindered access to top-of-line care). The Wound Company is not a solution for a privileged few—our platform was designed with the most vulnerable patients in mind.
Our wound care experts are just that—experts. They have decades of experience and gold standard certifications in wound and ostomy care (e.g. CWOCN) because we know that no two wound or ostomy patients are the same.
The Wound Company meets the growing challenges of wound and ostomy care in any market, blending in-person and telehealth support.
Our Chief Medical Officer Sanford Roberts is a general surgeon by training with over 35 peer-reviewed publications and several NIH grants to his name. Also, as a community advocate that co-founded a medical pipeline program for at-risk youth in West Philadelphia, Sanford illustrates that reimagining wound and ostomy care cannot move forward without passion and determination. Julie Roskamp, our Head of Care Delivery, shares the same commitment. She has been a certified wound ostomy and continence nurse for 30 years and has experience helping patients in every site of care as part of a private practice she led for nearly two decades. Our entrepreneurial clinical leadership helps to ensure The Wound Company is outstanding in our medical care and that our personalized, holistic approach equitably and truly impacts patient outcomes. With continuous, on-demand availability for both patients and providers, our entire team works tirelessly to ensure patients are truly getting the care they need before they need to ask for it.
So what’s next for The Wound Company?
We’ve proven our approach works. So over the coming year, we’re doubling down on our proven methods and expanding our market to ensure more patients have access to the care they deserve.
Expanding access to care. As you’re reading this, our team is continuing to foster relationships with and expand existing relationships with health plans, health systems, home care, and hospice providers. Our patient volume continues to grow by orders of magnitude, and we’re working hard to ensure everyone who needs wound and ostomy care has access to it either through their provider or health plan.
Growing national footprint. In the coming months, we’re continuing to roll out virtual and in-person care across additional regions as we expand our national footprint.
Continuing to invest in technology and team with venture capital funding. Our $4.25M in seed funding will help us scale our proven model and continue to invest in technology like our predictive analytics to enable targeted hands-on care when and where it's needed most. We’ll continue the R&D that has already allowed us to drive stronger outcomes, and we’re hiring passionate and experienced teammates to expand our impact.
Whether you’re a patient exploring treatment options, a home care company looking to increase its expertise, or a health plan aiming to provide the best health outcomes to its members, I look forward to supporting you on your journey to better wound and ostomy care.
Nima Ahmadi
Co-founder and CEO, The Wound Company